Bausch Health downgraded to Neutral from Overweight at Piper Sandler By: TalkMarkets January 22, 2021 at 08:34 AM EST Piper Sandler analyst David Amsellem downgraded Bausch Health to Neutral from Overweight with a price target of $30, up from $25. Read More >> Related Stocks: Bausch Health Companies Inc